IASLC Studying Impact of COVID-19 on International Lung Cancer Clinical Trial Enrollment, Mitigation Strategies

Cancer Clinical Trial Compensation: Undue or Long Overdue?

Revised U.S. Food and Drug Administration Trial Eligibility Guidance: A Major Step Toward Transforming Lung Cancer Clinical Trials

The New WHO Classification of Lung Tumors

Lung Cancer Biomarker Testing Patterns Varied Widely in Japan

3D Model of Lung Nodules Reduces Anxiety for Patients While Helping Them Understand Their Cancer Risk

Modeling Analyses Show That Expansions in Lung Cancer Screening Guidelines to Better Capture Underrepresented Populations Still Need Work

Improved Screening Uptake Could Help Double Lung Cancer Survival by 2025

Lung Cancer Screening Study in East Asia Successful at Identifying Early-Stage Disease

Increasing Adherence to CT Lung Cancer Screening Programs

Association of Race with Lung Cancer Risk Among Adults Undergoing Lung Cancer Screening

Ongoing Research Looks at Optimizing Lung Cancer Screening Programs